Literature DB >> 25422669

Adverse cutaneous drug reactions.

Neda Adibi1.   

Abstract

Entities:  

Year:  2014        PMID: 25422669      PMCID: PMC4235104     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


× No keyword cloud information.
Sir, I have red the valuable manuscript entitled: “Profile of adverse cutaneous drug reactions (ACDRs) in Dermatology Department of University Hospital in Center of Iran.” Mokhtari F., JRMS Augest 2014, page. It is about a very important challenging area in the field of medicine. The cutaneous side effects of several medications specially antibiotics and anticonvulsants may interfere with patients’ compliance and also may lead to life-threatening events. The physicians should think about several precautions that should think about before prescribing any drugs especially the high risked ones in order to decrease the risk of ACDR: The previous history of drug hypersensitivities in the patients should be asked to prevent a recurrence by the same category or the drugs with the same structure. The other medications that the patient is using simultaneously are so important to be checked to prevent higher risk due to multi-drug therapy. Any underlying disease in the end organs of metabolisms like kidney and liver should be detected to prevent drug accumulation and over dose due to impaired metabolism. The high-risk patients such as children, pregnant women, and older patients have a higher risk of ACDR in the skin and should be managed cautiously. The drugs that may interfere with the activity of the cytochrome P450 pathway may accelerate the drug hypersensitivity and drug cross reactions.[12] Finally, the authors detected a higher prevalence of more serious and life-threatening types of ACDR like Stevens Johnson and toxic epidermal necrolysis in their study. This finding is so important and may be due to the difference in type and potency of metabolic pathways in Iranian patients due to their ethnic groups, or it may be due to not including the above mentioned risk factors by the authors in their assessment.[3] It is recommended to pay enough attention to risk factors of increasing drug hypersensitivity reactions during prescription of any drug especially those with higher risk of ACDR.[4]
  4 in total

1.  Adverse cutaneous drug reactions: clinical pattern and causative agents in a tertiary care center in South India.

Authors:  David Pudukadan; Devinder Mohan Thappa
Journal:  Indian J Dermatol Venereol Leprol       Date:  2004 Jan-Feb       Impact factor: 2.545

Review 2.  Life-threatening acute adverse cutaneous drug reactions.

Authors:  Ronni Wolf; Edith Orion; Batsheva Marcos; Hagit Matz
Journal:  Clin Dermatol       Date:  2005 Mar-Apr       Impact factor: 3.541

3.  Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients.

Authors:  Fatemeh Mokhtari; Zahra Nikyar; Bahareh Abtahi Naeini; Alireza Asemi Esfahani; Siamak Rahmani
Journal:  J Res Med Sci       Date:  2014-08       Impact factor: 1.852

4.  Adverse cutaneous drug reaction.

Authors:  Surajit Nayak; Basanti Acharjya
Journal:  Indian J Dermatol       Date:  2008-01       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.